Yesterday, we helped TMX Group close the market for the 20th Shorcan Charity Day! For the last 20 years, Shorcan Brokers Limited has donated one day’s profits to charities, including Fighting Blindness…

Unless there is a research breakthrough very soon, Shelagh Anson’s children will lose their sight in their teens. Rowan and Caroline were born with Usher Syndrome, a disease that affects hearing and…

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…

In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia,…

In medicine, innovative treatments don’t emerge out of thin air. They are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye…

Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field…